The following factors were found to be significantly (p < 0.05) associated with the odds of experiencing pCR based on univariate logistic regression analyses (Table 3): clinical lymph node status, clinical tumor stage, tumor grade, ER status, PR status, HER2 status, MammaPrint result, and BluePrint result. This evidence concerns the gene ERBB2 and neoplasm.